Corrigendum: An immunogenic personal neoantigen vaccine for patients with melanoma

Corrigendum: An immunogenic personal neoantigen vaccine for patients with melanoma Nature 555, 7696 (2018). doi:10.1038/nature25145 Author: Patrick A. Ott, Zhuting Hu, Derin B. Keskin, Sachet A. Shukla, Jing Sun, David J. Bozym, Wandi Zhang, Adrienne Luoma, Anita Giobbie-Hurder, Lauren Peter, Christina Chen, Oriol Olive, Todd A. Carter, Shuqiang Li, David J. Lieb, Thomas Eisenhaure, Evisa Gjini, Jonathan Stevens, William J. Lane, Indu Javeri, Kaliappanadar Nellaiappan, Andres M. Salazar, Heather Daley, Michael Seaman, Elizabeth I. Buchbinder, Charles H. Yoon, Maegan Harden, Niall Lennon, Stacey Gabriel, Scott J. Rodig, Dan H. Barouch, Jon C. Aster, Gad Getz, Kai Wucherpfennig, Donna Neuberg, Jerome Ritz, Eric S. Lander, Edward F. Fritsch, Nir Hacohen & Catherine J. Wu Nature547, 217–221 (2017); doi:10.1038/nature22991In this Letter, the ‘Data availability’ section in the Methods should state ‘WES and RNA-seq data are deposited in dbGaP (https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001451.v1.p1). All other data are available from the corresponding author upon
Source: Nature - Category: Research Authors: Tags: Corrigendum Source Type: research